ETF PRO AIOctober 7, 2026
XBI SPDR S&P Biotech ETF
Fund tearsheet · data as of the latest session · October 7, 2026
ONE YEAR OF DAILY CLOSES
0.35%expense ratio
$10.3Bfund assets
+23.8%return, YTD
+45.6%return, 1 year
−$567Mnet flow, 1 month
+$935Mnet flow, 1 year
28.3%realized volatility, 1y
-11.0%worst drawdown, 1y
Top ten holdings
| 1 | MRNA MODERNA | 1.41% |
| 2 | TWST TWIST BIOSCIENCE | 1.40% |
| 3 | GRAL GRAIL INC | 0.90% |
| 4 | IOVA IOVANCE BIOTHERAPEUTICS | 0.56% |
| 5 | NTRA NATERA | 1.16% |
| 6 | HALO HALOZYME THERAPEUTICS | 1.03% |
| 7 | PCVX VAXCYTE | 1.18% |
| 8 | KOD KODIAK SCIENCES | 0.54% |
| 9 | RVMD REVOLUTION MEDICINES | 1.20% |
| 10 | KYMR KYMERA THERAPEUTICS | 1.35% |
PREPARED WITH ETF PRO AI · PRIMARY MARKET DATA · INFORMATIONAL ONLY — NOT AN OFFER, RECOMMENDATION, OR INVESTMENT ADVICE · PAST PERFORMANCE DOES NOT GUARANTEE FUTURE RESULTS